[Systemic therapy of metastatic bladder cancer]

M Retz; S C Schmid; M W Kramer; A S Merseburger

doi:10.1007/s00120-013-3250-1

[Systemic therapy of metastatic bladder cancer]

Urologe A. 2013 Oct 13. doi: 10.1007/s00120-013-3250-1. Online ahead of print.

[Article in German]

Authors

M Retz¹, S C Schmid, M W Kramer, A S Merseburger

Affiliation

¹ Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, München, Deutschland, margitta.retz@lrz.tum.de.

PMID: 24121473
DOI: 10.1007/s00120-013-3250-1

Abstract

This review focuses on current options in the medical therapy of metastasized urothelial carcinoma of the bladder. Standard treatments as well as new, recently published therapeutic approaches are evaluated and discussed.